Barclays’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27K | Sell |
21,688
-82,720
| -79% | -$103K | ﹤0.01% | 4043 |
|
|
2025
Q1 | $96K | Sell |
104,408
-41,009
| -28% | -$37.7K | ﹤0.01% | 3709 |
|
|
2024
Q4 | $231K | Buy |
145,417
+15,578
| +12% | +$24.7K | ﹤0.01% | 3446 |
|
|
2024
Q3 | $255K | Buy |
129,839
+71,463
| +122% | +$140K | ﹤0.01% | 3365 |
|
|
2024
Q2 | $97K | Sell |
58,376
-38,857
| -40% | -$64.6K | ﹤0.01% | 3391 |
|
|
2024
Q1 | $499K | Sell |
97,233
-166,238
| -63% | -$853K | ﹤0.01% | 2837 |
|
|
2023
Q4 | $1.51M | Buy |
263,471
+9,240
| +4% | +$53K | ﹤0.01% | 2338 |
|
|
2023
Q3 | $1.22M | Buy |
254,231
+236,020
| +1,296% | +$1.13M | ﹤0.01% | 1949 |
|
|
2023
Q2 | $77K | Sell |
18,211
-82,981
| -82% | -$351K | ﹤0.01% | 3497 |
|
|
2023
Q1 | $538K | Sell |
101,192
-18,899
| -16% | -$100K | ﹤0.01% | 2596 |
|
|
2022
Q4 | $754K | Buy |
120,091
+36,690
| +44% | +$230K | ﹤0.01% | 2332 |
|
|
2022
Q3 | $880K | Buy |
83,401
+80,692
| +2,979% | +$851K | ﹤0.01% | 2224 |
|
|
2022
Q2 | $15K | Sell |
2,709
-5,660
| -68% | -$31.3K | ﹤0.01% | 4191 |
|
|
2022
Q1 | $77K | Buy |
+8,369
| New | +$77K | ﹤0.01% | 3797 |
|